Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement-Reference-Cited by-同舟云学术

Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement

Published:2015-04-01 Issue:10 Volume:262 Page:2201-2213
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Albanese Alberto,Abbruzzese Giovanni,Dressler Dirk,Duzynski Wojciech,Khatkova Svetlana,Marti Maria Jose,Mir Pablo,Montecucco Cesare,Moro Elena,Pinter Michaela,Relja Maja,Roze Emmanuel,Skogseid Inger Marie,Timerbaeva Sofiya,Tzoulis Charalampos

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/article/10.1007/s00415-015-7703-x/fulltext.html

Reference94 articles.

1. Charles PD, Adler CH, Stay M et al (2014) Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). J Neurol 261:13019–13098

2. Camfield L, Ben-Shlomo T, Warner TT (2002) Impact of cervical dystonia on quality of life. Mov Disord 17:838–841

3. Jankovic J, Adler CH, Charles PD et al (2011) Rational and design of a prospective study: cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE). BMC Neurology 11:140

4. Swope D, Barbano R (2008) Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia. Neurol Clin 26(Suppl 1):54–65

5. Albanese A, Asmus F, Bhatia KP et al (2011) EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 18:5–18

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment response to onabotulinumtoxinA in cervical dystonia patients with anterocollis and retrocollis;Toxicon;2024-09

2. Duration of botulinum toxin efficacy in cervical dystonia clinical trials: A scoping review;Parkinsonism & Related Disorders;2024-08

3. Embracing the Versatility of Botulinum Neurotoxins in Conventional and New Therapeutic Applications;Toxins;2024-06-04

4. Cervical motion alterations and brain functional connectivity in cervical dystonia;Parkinsonism & Related Disorders;2024-03

5. Abstracts;Movement Disorders Clinical Practice;2024-02